APOA1 and Alzheimer disease: Plasma ApoA-I levels also tended to decrease in AD patients in the Caucasian population compared with HCs, but the difference was not significant [SMD = −1.44; 95% CI (−3.42, −0.55); P = 0.155; Table 3].